
Opinion|Videos|January 17, 2025
Key Unmet Needs in IPF and PPF
Author(s)Anna Podolanczuk, M.D., M.S.
Anna Podolanczuk, M.D., M.S., discusses the key unmet needs in diagnosing idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF), and how artificial intelligence (AI) could play a transformative role in enabling earlier detection of these diseases in the future.
Advertisement
Episodes in this series

Video content above is prompted by the following:
What are the key unmet needs in diagnosing IPF and PPF, and how do you see AI impacting earlier detection of the disease in the future?
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
USPS Woes Continue: Health Plans, Be Prepared
2
Updated: FDA approves first-in-class therapy for metastatic pancreatic cancer
3
FDA approves Tevimbra and Ziihera for HER2-positive gastroesophageal cancer
4
AI-assisted nodule detection could boost early lung cancer diagnosis
5
























